From: Antifungal treatment for invasive Candida infections: a mixed treatment comparison meta-analysis
Treatment Comparison | Odds Ratio | 95% Credible Interval |
---|---|---|
Caspofungin vs. Fluconazole | 2.03 | (0.98, 3.76) |
Amphotericin B Deoxycholate vs. Fluconazole | 1.13 | (0.78, 1.58) |
Amphotericin B Liposomal vs. Fluconazole | 1.85 | (0.65, 4.19) |
Voriconazole vs. Fluconazole | 1.14 | (0.62, 1.94) |
Micafungin vs. Fluconazole | 2.13 | (0.83, 4.55) |
Anidulafungin vs. Fluconazole | 2.14 | (1.19, 3.58) |
Itraconazole vs. Fluconazole | 1.97 | (0.32, 6.69) |
Amphotericin B Deoxycholate vs. Caspofungin | 0.60 | (0.32, 1.02) |
Amphotericin B Liposomal vs. Caspofungin | 0.91 | (0.45, 1.63) |
Voriconazole vs. Caspofungin | 0.61 | (0.27, 1.18) |
Micafungin vs. Caspofungin | 1.04 | (0.59, 1.70) |
Anidulafungin vs. Caspofungin | 1.18 | (0.45, 2.56) |
Itraconazole vs. Caspofungin | 1.05 | (0.16, 3.72) |
Amphotericin B Liposomal vs. Amphotericin B Deoxycholate | 1.64 | (0.63, 3.52) |
Voriconazole vs. Amphotericin B Deoxycholate | 1.01 | (0.63, 1.54) |
Micafungin vs. Amphotericin B Deoxycholate | 1.88 | (0.80, 3.79) |
Anidulafungin vs. Amphotericin B Deoxycholate | 1.96 | (0.96, 3.58) |
Itraconazole vs. Amphotericin B Deoxycholate | 1.74 | (0.30, 5.77) |
Voriconazole vs. Amphotericin B Liposomal | 0.75 | (0.25, 1.74) |
Micafungin vs. Amphotericin B Liposomal | 1.18 | (0.81, 1.68) |
Anidulafungin vs. Amphotericin B Liposomal | 1.44 | (0.42, 3.66) |
Itraconazole vs. Amphotericin B Liposomal | 1.28 | (0.16, 4.86) |
Micafungin vs. Voriconazole | 1.95 | (0.72, 4.31) |
Anidulafungin vs. Voriconazole | 2.03 | (0.85, 4.13) |
Itraconazole vs. Voriconazole | 1.81 | (0.28, 6.22) |
Anidulafungin vs. Micafungin | 1.21 | (0.38, 2.94) |
Itraconazole vs. Micafungin | 1.08 | (0.14, 3.99) |
Itraconazole vs. Anidulafungin | 0.99 | (0.14, 3.56) |